Aaron Ogden uses his scientific and patent practice experience to develop practical strategies to protect and leverage his clients' intellectual property. His practice is focused on intellectual property portfolio management, prosecution of complex patent applications, infringement analysis, due diligence and patentability and patent landscape searches. He assists clients in a wide range of technologies such as mRNA therapeutics and vaccines, antibody and cell therapies, gene therapy and AAV capsid engineering, gene editing, cancer diagnostics and microbiome and biotherapeutic platforms.
Before moving into patent practice, Aaron worked as a scientist, combining wet-lab molecular biology with high-throughput proteomics, metabolomics and transcriptomics to study plant and bacterial physiology, plant–microbe interactions and stress responses, where he developed an invaluable understanding of the life sciences industry. He now assists clients with intellectual property portfolio management, patent prosecution, infringement analysis, freedom-to-operate and patent landscape assessments and intellectual property due diligence in connection with company acquisitions.
Representative experience
Representative experience:
- Experience handling cases relating to large‑molecule therapeutic platforms, including gene therapy programs involving AAV capsid engineering, payload delivery and mRNA‑based therapeutics for cancer and infectious disease vaccines; industry portfolio experience covering protein therapeutics and methods for identifying, selecting and incorporating neoantigens and neoepitopes into mRNA‑based vaccines; protein and peptide‑based therapeutics; antibodies across multiple formats (including antibody–drug conjugates); CAR‑ and T‑cell‑related technologies; gene‑editing applications using Cas enzymes, zinc finger nucleases and TALENs; and biologic modalities including antibodies, cytokines, mRNA, siRNA and miRNA; as well as stem cell‑, fibroblast‑ and mesenchymal stem cell (MSC)‑, pancreatic islet organoid-based technologies.
- Experience handling cases relating to companion diagnostic methodologies, including approaches that measure disease‑associated biomarkers to guide therapeutic decision‑making based on defined thresholds, across multiple indications such as cancer and infectious diseases and therapeutic modalities including antibody‑based treatments.
- Executing experiments with microbiome and biotherapeutic technologies, including microbial biosensors, microbiome characterization and engineering informed by doctoral training in data science, proteomics, metabolomics, transcriptomics, microbial and plant physiology, bacterial–host interactions, small‑molecule modulation of microbial ecology and function, high‑throughput microbial screening and phenotyping for therapeutic development and microbiome transplantation and synthetic microbial consortium approaches.
Education
- PhD, Doctor of Philosophy in Molecular Plant Science, Washington State University Institute of Biological Chemistry, 2018
- BS, Botany and Chemistry, Weber State University, 2011
Admissions
- US Patent and Trademark Agent
Publications
- Co-author, Sorgoleone degradation by sorghum-associated bacteria; an opportunity for enforcing plant growth promotion," bioRxiv, 2023.
- Co-author, “CO2 supplementation eliminates sugar-rich media requirement for plant propagation using a simple inexpensive temporary immersion photobioreactor,” Plant Cell, Tissue and Organ Culture, 2022.
- Co-author, “Science forum: Vision, challenges and opportunities for a Plant Cell Atlas,” Elife, 2021.
- Co-author, “Unbalancing Symbiotic Nitrogen Fixation: Can We Make Effectiveness More Effective?,” US Department of Energy Office of Scientific and Technical Information, 2021.
- Co-author, “Crops for Carbon Farming,” Frontiers in Plant Science, 2021.
- Co-author, “First plant cell atlas workshop report,” Plant Direct, 2020.
- Co-author, “Distinct Preflowering Drought Tolerance Strategies of Sorghum bicolor Genotype RTx430 Revealed by Subcellular Protein Profiling,” International Journal of Molecular Sciences, 2020.
- Co-author, “Characterization of Local and Systemic Impact of Whitefly (Bemisia tabaci) Feeding and Whitefly-Transmitted Tomato Mottle Virus Infection on Tomato Leaves by Comprehensive Proteomics,” International Journal of Molecular Sciences, 2020.
- Co-author, “Phloem exudate protein profiles during drought and recovery reveal abiotic stress responses in tomato vasculature,” International Journal of Molecular Sciences, 2020.
- Co-author, “Dynamics of Global Gene Expression and Regulatory Elements in Growing Brachypodium Root System,” Scientific Reports, 2020.
- Co-author, “Characterization of the Sinorhizobium meliloti HslUV and ClpXP protease systems in free-living and symbiotic states,” Journal of Bacteriology, 2019.
- Co-author, “Phragmoplast microtubule dynamics–a game of zones,” Journal of Cell Science, 2018.
- Co-author, “Integrated analysis of zone-specific protein and metabolite profiles within nitrogen-fixing Medicago truncatula-Sinorhizobium medicae nodules. PLoS One, 2017.
Membership and activities
- Editorial Board Member, Frontiers in Analytical Science